Get the Stockscreener App
1.10
4.35%
-0.05
Cardiol Therapeutics Inc Stock (CRDL) Forecast
The Cardiol Therapeutics Inc (CRDL) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.6998, representing a -36.38% decrease from the current price of $1.10. The highest analyst price target is $0.9856, and the lowest is $0.4141.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CRDL Price Target
Average 0.5045
(-54.14% Downside)
Is Cardiol Therapeutics Inc (CRDL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 20.47 | Buy |
| STOCH(9,6) | 3.4057 | Buy |
| STOCHRSI(14) | 7.8067 | Buy |
| MACD(12,26) | -0.1848 | Sell |
| ADX(14) | 38.80 | Sell |
| William %R | -97.60 | Buy |
| CCI(14) | -58.30 | Neutral |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.225
Sell
|
1.2493
Sell
|
| MA20 |
1.461
Sell
|
1.4093
Sell
|
| MA50 |
1.733
Sell
|
1.5467
Sell
|
| MA100 |
1.4349
Sell
|
1.4905
Sell
|
| MA200 |
1.2957
Sell
|
1.3849
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CRDL could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on CRDL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 20.47 indicates that CRDL is oversold. This indicates that CRDL price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 3.4057 indicates that CRDL is oversold. This indicates that CRDL price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 7.8067 indicates that CRDL is oversold. This suggests that CRDL price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 38.8 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -58.3 indicates that CRDL is still oversold but not to an extreme extent.
Long-term CRDL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cardiol Therapeutics Inc financial reports and earnings history, Cardiol Therapeutics Inc (CRDL) stock could reach $1.6556 by 2030, $2.4791 by 2040 and $5.3691 by 2050. See the projected annual prices until 2050 of the Cardiol Therapeutics Inc stock below:
- Cardiol Therapeutics Inc (CRDL) is expected to reach an average price of $0.1577 in 2035, with a high prediction of $0.8702 and a low estimate of $0.2676. This indicates an $-85.66% rise from the last recorded price of $1.10.
- Cardiol Therapeutics Inc (CRDL) stock is projected to chart a bullish course in 2040, with an average price target of $2.4582, representing an $123.47% surge from its current level. The forecast ranges from a conservative $2.412 to a sky-high $2.4791.
- Our analysts predict Cardiol Therapeutics Inc (CRDL) to jump 286.13% by 2045, soaring from $4.2758 to an average price of $4.2474, potentially reaching $4.2372. While $4.2758 is the low estimate, the potential upside is significant.
- Cardiol Therapeutics Inc (CRDL) stock is expected to climb by 2050, reaching an average of $5.325, a $384.09% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.3691 and $5.3855, respectively, highlighting the market's uncertainty.
Cardiol Therapeutics Inc Stock (CRDL) Year by Year Forecast
Cardiol Therapeutics Inc Stock (CRDL) Price Forecast for 2026
The predicted value for Cardiol Therapeutics Inc (CRDL) in 2026 is set at an average of $1.3157. Estimates vary from a peak of $2.3733 to a trough of $0.2581, indicating an +19.61% surge from the present price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.6769 | $0.4141 | $0.9856 | -38.47% |
| December, 2026 | $0.2681 | $0.2581 | $0.7197 | -75.62% |
Cardiol Therapeutics Inc Stock (CRDL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cardiol Therapeutics Inc (CRDL) is $0.4836, with a high forecast of $0.9438 and a low forecast of $0.0234. This indicates an -56.04% decrease from the last price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.4394 | $0.131 | $0.9438 | -60.05% |
| February, 2027 | $0.1707 | $0.0693 | $0.5021 | -84.49% |
| March, 2027 | $0.0153 | $0.0353 | $0.4262 | -98.61% |
| April, 2027 | $0.676 | $0.0604 | $0.706 | -38.55% |
| May, 2027 | $0.22 | $0.0484 | $0.6688 | -80.00% |
| June, 2027 | $0.1613 | $0.0286 | $0.3113 | -85.34% |
| July, 2027 | $0.00256 | $0.0357 | $0.3597 | -99.77% |
| August, 2027 | $0.0366 | $0.0234 | $0.1238 | -96.67% |
| September, 2027 | $0.1921 | $0.1977 | $0.1249 | -82.54% |
| October, 2027 | $0.2009 | $0.1737 | $0.1293 | -81.74% |
| November, 2027 | $0.7008 | $0.3009 | $0.6589 | -36.29% |
| December, 2027 | $0.75 | $0.6998 | $0.6783 | -31.82% |
Cardiol Therapeutics Inc Stock (CRDL) Price Forecast for 2028
In 2028, Cardiol Therapeutics Inc (CRDL) is projected to reach an average price of $0.4186, with a high projection of $0.7399 and a low estimate of $0.0973. This indicates an -61.94% fall from the last price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.6037 | $0.6141 | $0.7399 | -45.12% |
| February, 2028 | $0.4446 | $0.6736 | $0.6959 | -59.58% |
| March, 2028 | $0.5305 | $0.5589 | $0.512 | -51.77% |
| April, 2028 | $0.6973 | $0.6461 | $0.6527 | -36.61% |
| May, 2028 | $0.7263 | $0.7209 | $0.7036 | -33.97% |
| June, 2028 | $0.5828 | $0.6401 | $0.7029 | -47.02% |
| July, 2028 | $0.5142 | $0.5301 | $0.5618 | -53.25% |
| August, 2028 | $0.3455 | $0.3662 | $0.4856 | -68.59% |
| September, 2028 | $0.2887 | $0.3814 | $0.2811 | -73.76% |
| October, 2028 | $0.2117 | $0.0973 | $0.1757 | -80.75% |
| November, 2028 | $0.2005 | $0.1533 | $0.1289 | -81.78% |
| December, 2028 | $0.2792 | $0.2348 | $0.1892 | -74.62% |
Cardiol Therapeutics Inc Stock (CRDL) Price Forecast for 2029
The 2029 price forecast for Cardiol Therapeutics Inc Stock (CRDL) is $1.0616 on average, with a high prediction of $2.1062 and a low estimate of $0.0171. This represents an -3.49% decrease from the previous price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.2686 | $0.3158 | $0.2679 | -75.58% |
| February, 2029 | $0.1874 | $0.247 | $0.2423 | -82.97% |
| March, 2029 | $0.2576 | $0.1911 | $0.188 | -76.58% |
| April, 2029 | $0.1915 | $0.0385 | $0.2179 | -82.60% |
| May, 2029 | $0.3627 | $0.0171 | $0.4127 | -67.03% |
| June, 2029 | $0.444 | $0.384 | $1.1111 | -59.64% |
| July, 2029 | $0.818 | $0.2968 | $1.0252 | -25.63% |
| August, 2029 | $0.9593 | $0.5108 | $1.0466 | -12.79% |
| September, 2029 | $1.6005 | $0.9221 | $1.6405 | +45.50% |
| October, 2029 | $0.9746 | $0.689 | $2.1062 | -11.40% |
| November, 2029 | $1.1659 | $0.8274 | $1.3731 | +5.99% |
| December, 2029 | $0.9599 | $0.8215 | $1.1987 | -12.73% |
Cardiol Therapeutics Inc Stock (CRDL) Price Forecast for 2030
Cardiol Therapeutics Inc Stock (CRDL) is expected to reach an average price of $0.8319 in 2030, with a high forecast of $1.6556 and a low forecast of $0.00818. This signifies an -24.37% decrease from the last price of $1.10.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.1012 | $0.7978 | $1.6556 | +0.11% |
| February, 2030 | $0.9625 | $0.5996 | $1.1028 | -12.50% |
| March, 2030 | $1.0437 | $0.7981 | $1.2937 | -5.12% |
| April, 2030 | $0.3978 | $0.3628 | $1.1265 | -63.84% |
| May, 2030 | $0.519 | $0.2934 | $0.539 | -52.81% |
| June, 2030 | $0.5003 | $0.2547 | $0.5919 | -54.52% |
| July, 2030 | $0.2694 | $0.1615 | $0.6031 | -75.51% |
| August, 2030 | $0.0854 | $0.00818 | $0.33 | -92.23% |
| September, 2030 | $0.2297 | $0.0468 | $0.3097 | -79.12% |
| October, 2030 | $0.2409 | $0.1789 | $0.3281 | -78.10% |
| November, 2030 | $0.3922 | $0.2138 | $0.6494 | -64.35% |
| December, 2030 | $0.3563 | $0.3063 | $0.7006 | -67.61% |
9.94%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):